搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
1 小时
‘The Virgin of the Quarry Lake’ Review: Adolescent Envy Turns Deadly in an Atmospheric ...
In her debut 'The Virgin of the Quarry Lake,' Laura Casabé brings much humid mood to an enigmatic script by leading local ...
1 小时
Palantir Earnings: Why I'm Changing My Stance (Rating Upgrade)
Palantir's Q4 earnings report was strong, with commercial revenues up 64% y/y. Read why I upgrade PLTR stock from sell to buy.
13 小时
Enhabit: Healthcare Predictive Analytics, FCF, Very Undervalued
EHAB appears substantially undervalued, taking into account the company's cash flow and positive net income. This implies ...
17 小时
Inter & Co, Inc. (INTR): A Cheap Bank Stock to Invest In Before It Takes Off
We recently compiled a list of the 7 Cheap Bank Stocks To Invest In Before They Take Off. In this article, we are going to ...
3 天
Somehow, some way, Edge has over 30% market share in the US on Windows—and has taken ...
Nadella further detailed the growth, sharing, "Search and News advertising revenue ex-TAC increased 21% and 20% in constant ...
4 天
Are You An Alpha Female? Why Some Consider You A Threat
The funny thing about alpha females is that they rarely call themselves that. They don’t have to. Their presence speaks for itself—calm, collected, and undeniably powerful. They aren’t the loudest in ...
6 天
on MSN
Seeking Alpha Review: Best Investment Websites to Research Stocks
We recently published a list of the 12 Best Investment Websites To Research Stocks. In this article, we will look at where ...
Daily
6 天
Merck WELIREG gets USFDA priority review for Advanced Pheochromocytoma and Paraganglioma
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA ...
Contract Pharma
7 天
Merck’s WELIREG Accepted for Priority Review by FDA for Pheochromocytoma and Paraganglioma
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
7 天
Merck: FDA grants priority review to sNDA for Welireg
Merck (MRK) announced the U.S. FDA has accepted for priority review a supplemental new drug application seeking approval of Welireg, Merck’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈